Source Natural Foods & Herbal Supplements Ltd
Incorporated in 1998, Source Natural Foods
and Herbal Supplements Ltd provides Ayurveda, Health & Dietary Supplements and Food Products[1]
- Market Cap ₹ 83.7 Cr.
- Current Price ₹ 130
- High / Low ₹ 270 / 78.0
- Stock P/E 32.1
- Book Value ₹ 32.2
- Dividend Yield 0.00 %
- ROCE 18.5 %
- ROE 9.52 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
- Company's working capital requirements have reduced from 145 days to 115 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 12.7% over last 3 years.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3.76 | 4.54 | 6.54 | 10.93 | 15.94 | 10.84 | 12.81 | 13.59 | 24.88 | 21.53 | 19.79 | 27.30 | 35.70 | |
3.16 | 4.12 | 5.83 | 9.97 | 14.12 | 9.43 | 11.22 | 11.20 | 20.71 | 17.68 | 16.18 | 22.83 | 30.30 | |
Operating Profit | 0.60 | 0.42 | 0.71 | 0.96 | 1.82 | 1.41 | 1.59 | 2.39 | 4.17 | 3.85 | 3.61 | 4.47 | 5.40 |
OPM % | 15.96% | 9.25% | 10.86% | 8.78% | 11.42% | 13.01% | 12.41% | 17.59% | 16.76% | 17.88% | 18.24% | 16.37% | 15.13% |
0.00 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.02 | 0.33 | 0.49 | 0.01 | -0.04 | -0.03 | |
Interest | 0.00 | 0.00 | 0.01 | 0.01 | 0.07 | 0.24 | 0.20 | 0.23 | 0.10 | 0.24 | 0.27 | 0.21 | 0.50 |
Depreciation | 0.25 | 0.26 | 0.54 | 0.49 | 0.35 | 0.35 | 0.34 | 0.34 | 0.37 | 0.42 | 0.62 | 1.04 | 1.03 |
Profit before tax | 0.35 | 0.17 | 0.16 | 0.47 | 1.41 | 0.83 | 1.05 | 1.84 | 4.03 | 3.68 | 2.73 | 3.18 | 3.84 |
Tax % | 0.00% | 0.00% | 0.00% | 10.64% | 0.71% | 3.61% | 2.86% | 11.41% | 16.38% | 33.97% | 22.71% | 45.28% | |
0.35 | 0.17 | 0.16 | 0.43 | 1.40 | 0.80 | 1.03 | 1.64 | 3.37 | 2.43 | 2.12 | 1.74 | 2.60 | |
EPS in Rs | 0.78 | 0.33 | 0.26 | 0.67 | 2.17 | 1.24 | 1.60 | 2.55 | 5.24 | 3.78 | 3.29 | 2.70 | 4.03 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 62.52% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 20% |
5 Years: | 16% |
3 Years: | 3% |
TTM: | 31% |
Compounded Profit Growth | |
---|---|
10 Years: | 26% |
5 Years: | 11% |
3 Years: | -19% |
TTM: | -2% |
Stock Price CAGR | |
---|---|
10 Years: | 23% |
5 Years: | 13% |
3 Years: | 11% |
1 Year: | 34% |
Return on Equity | |
---|---|
10 Years: | 15% |
5 Years: | 16% |
3 Years: | 13% |
Last Year: | 10% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4.50 | 5.20 | 6.10 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 |
Reserves | -2.09 | -0.15 | -0.96 | -0.88 | 0.53 | 1.33 | 2.36 | 3.35 | 6.73 | 9.16 | 11.28 | 13.02 | 14.28 |
2.22 | 0.00 | 0.09 | 0.08 | 1.91 | 1.77 | 0.16 | 1.12 | 0.93 | 0.04 | 0.02 | 0.00 | 6.30 | |
0.33 | 0.45 | 0.77 | 0.98 | 2.63 | 1.56 | 1.84 | 2.23 | 3.13 | 3.69 | 3.96 | 4.19 | 4.27 | |
Total Liabilities | 4.96 | 5.50 | 6.00 | 6.62 | 11.51 | 11.10 | 10.80 | 13.14 | 17.23 | 19.33 | 21.70 | 23.65 | 31.29 |
3.48 | 3.87 | 3.66 | 3.31 | 3.53 | 3.58 | 3.57 | 3.31 | 3.88 | 5.00 | 6.56 | 5.52 | 5.01 | |
CWIP | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.34 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
1.47 | 1.63 | 2.34 | 3.31 | 7.98 | 7.52 | 7.23 | 9.83 | 13.01 | 14.33 | 15.14 | 18.13 | 26.28 | |
Total Assets | 4.96 | 5.50 | 6.00 | 6.62 | 11.51 | 11.10 | 10.80 | 13.14 | 17.23 | 19.33 | 21.70 | 23.65 | 31.29 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.49 | 0.00 | 0.38 | 0.38 | -0.69 | 0.11 | 2.64 | -0.36 | 4.46 | -0.70 | 2.51 | 2.69 | |
-0.30 | 0.00 | -0.40 | -0.16 | -1.95 | 0.14 | -0.31 | -0.71 | -2.09 | 0.07 | 0.06 | 0.29 | |
0.19 | 0.00 | 0.11 | 0.01 | 2.06 | -0.42 | -1.60 | 0.32 | 0.32 | -1.20 | -0.53 | -0.04 | |
Net Cash Flow | 0.38 | 0.00 | 0.08 | 0.23 | -0.58 | -0.18 | 0.74 | -0.74 | 2.69 | -1.83 | 2.04 | 2.95 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 11.65 | 28.14 | 12.84 | 27.72 | 100.52 | 139.06 | 94.88 | 182.37 | 87.88 | 131.22 | 136.67 | 100.41 |
Inventory Days | 142.99 | 143.08 | 218.30 | 143.24 | 115.92 | 202.88 | 149.49 | 92.38 | 64.09 | 106.83 | 141.55 | 93.53 |
Days Payable | 101.60 | 90.52 | 108.28 | 81.70 | 84.18 | 36.13 | 46.29 | 58.58 | 22.10 | 57.67 | 78.93 | 60.91 |
Cash Conversion Cycle | 53.04 | 80.70 | 122.86 | 89.26 | 132.26 | 305.81 | 198.08 | 216.16 | 129.86 | 180.37 | 199.29 | 133.04 |
Working Capital Days | 46.60 | 58.69 | 58.60 | 53.76 | 111.74 | 178.80 | 114.54 | 183.17 | 82.01 | 163.43 | 157.14 | 114.71 |
ROCE % | 8.28% | 3.51% | 3.31% | 8.83% | 20.39% | 11.62% | 13.51% | 20.84% | 33.11% | 26.36% | 17.97% | 18.49% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 14 Feb
-
Integrated Filing (Financial)
13 Feb - Integrated financial results for quarter ended 31 Dec 2024.
-
Integrated Filing (Financial)
13 Feb - Outcome of Board meeting and un-audited financial results.
- Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2024 13 Feb
-
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.Ie., 13Th February 2025 For Considering Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2024
13 Feb - Outcome of Board meeting and financial results for Q3 2024.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Product Profile:
a) Beverages:[1]
Ojasvita - Chocolate, Malt, Strawberry, Mango, Golden Latte, etc.
b) Supplements:[2]
Turmeric Plus, Amla, Yastimadhu, Triphala, Nishamlaki, Arjuna
c) Arkas:[3]
Shakti Drops, Tulsi Araka, Ajamoda Arka
d) Single Herbs:[4]
Shakhpushpi, Shatavari, Tulsi, Neem, Brahmi, Ashwagandha, Amrut, Kalamegh, Haritaki
e) Churnas:[5]
Sitophaladi, Hingvastaka, Triphala